Hawaiian Baby Woodrose is Uncontrolled in the United States, however, it is not approved for human consumption. This is a gray area of the law because the seeds contain, LSA, which is a Schedule III.
Addictive Potential: None
Emergency Room Visits Yearly: Unknown
Mandatory Minimum Sentence: None
Mechanism of Action: Partial agonist of the serotonin receptors
Hawaiian Baby Woodrose (Argyreia nervosa) is a perennial climbing vine, also known as Elephant Creeper and Woolly Morning Glory. This plant is a rare example of a plant whose hallucinogenic properties have only recently been discovered by non-Hawaiians. While its cousins in the Convolvulaceae family, such as the Rivea corymbosa (Ololiuhqui) and Ipomoea violacea (Morning Glory), were used in shamanic rituals of Latin America for centuries, the Hawaiian Baby Woodrose was not traditionally recognized as a hallucinogen. Its properties were first brought to attention in the 1960s, despite the fact that the chemical composition of its seeds is nearly identical to those of the two species mentioned above, and the seeds contain the highest concentration of psychoactive compounds in the entire family.
Hawaiian Baby Woodrose seeds contain LSA (d-lysergic acid amide), a precursor to LSD. The seeds are generally eaten, although there are a variety of preparation methods used. The active oral dosage ranges from 4 to 12 seeds and lasts from 4 to 8 hours. The LSA content of Argyreia nervosa is 0.14% of the dry weight of the seeds (Chao & Der Marderosian, 1973).
Side Effects and Adverse Reactions:
Some users commonly report experiencing anxiety, nausea, gas, vomiting, and abdominal cramps. Delirium, dizziness, confusion, paranoia, fear, and panic are less common, but sometimes experienced with higher doses (Erowid, 2009).
Hallucinogens and dissociative agents naturally growing in the United States – by John H. Halpern
Ergoline alkaloidal constituents of Hawaiian baby wood rose, Argyreia nervosa (Burm. f.) Bojer. – by JM Chao and AH Der Marderosian